NB Bancorp
NBBK · NASDAQ
About NBBK
- Employees
- 526
- Headquarters
- Needham, Massachusetts
- Listed
- Dec 28, 2023
- Sector
- Financials
- Industry
- Banks
- Website
- nbbancorp.com
NBBK key statistics
- Market cap
- 911.29M
- Price-earnings ratio
- 14.14
- Dividend yield
- 1.36%
- Average volume
- 245.84K
- Volume
- 611.63K
- Open price
- $21.59
- High today
- $22.38
- Low today
- $21.59
- 52 Week high
- $23.47
- 52 Week low
- $17.16
NB Bancorp (NBBK) at a glance
NB Bancorp (NBBK) last traded at $22.32, with a market cap of 911.29M, a price-to-earnings ratio of 14.14 and a dividend yield of 1.36%.
Today the stock has traded between $21.59 and $22.38. The current price is 3.4% above the day's low and 0.3% below its high.
Volume so far is 611.63K shares, above the average of 245.84K shares a day.
Over the past year NB Bancorp has ranged from $17.16 to $23.47, and now sits 82% of the way up that range.
NB Bancorp met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q3 FY26 it reported $0.60 per share against an estimate of $0.5967.
The average analyst price target is $26.01, 16.5% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $25.25
- Now
- $22.32
- High
- $27.30
NBBK earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 11.5% on average.
- Q4 FY24: reported $0.40 per share against an estimate of $0.3264
- Q1 FY25: reported $0.35 per share against an estimate of $0.3366
- Q2 FY25: reported $0.40 per share against an estimate of $0.357
- Q3 FY25: reported $0.50 per share against an estimate of $0.4284
- Q4 FY25: reported $0.51 per share against an estimate of $0.459
- Q1 FY26: reported $0.39 per share against an estimate of $0.5457
- Q2 FY26: reported $0.55 per share against an estimate of $0.4845
- Q3 FY26: reported $0.60 per share against an estimate of $0.5967
NBBK news
- Press releasePRNewswire
- Press releaseBusiness Wire
KBRA Assigns Ratings to NB Bancorp, Inc.
- Press releasePRNewswire
NB Bancorp, Inc. Reports Second Quarter 2026 Financial Results, Declares Quarterly Cash Dividend
- Press releasePRNewswire
NB Bancorp, Inc. Reports First Quarter 2026 Financial Results, Declares Quarterly Cash Dividend
- Press releasePRNewswire
NB Bancorp, Inc. Reports Fourth Quarter 2025 Financial Results, Declares Quarterly Cash Dividend, Announces Share Repurchase Plan
- Press releasePRNewswire
NB Bancorp, Inc. and Provident Bancorp, Inc. Announce Closing of Merger
- Press releasePRNewswire
NB Bancorp, Inc. and Provident Bancorp, Inc. Announce Final Proration of Merger Consideration
- Press releasePRNewswire
NB Bancorp, Inc. and Provident Bancorp, Inc. Announce Confirmation of Election Deadline for Merger Consideration and Expected Closing Date
Similar companies
Companies in the same industry as NB Bancorp
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.